Literature DB >> 1720697

Myeloid differentiation of purified CD34+ cells after stimulation with recombinant human granulocyte-monocyte colony-stimulating factor (CSF), granulocyte-CSF, monocyte-CSF, and interleukin-3.

T Egeland1, R Steen, H Quarsten, G Gaudernack, Y C Yang, E Thorsby.   

Abstract

CD34+ cells isolated from bone marrow or umbilical cord blood from healthy donors were studied for proliferation and differentiation in liquid cultures in the presence of recombinant human granulocyte-monocyte colony-stimulating factor (GM-CSF), granulocyte CSF (G-CSF), monocyte CSF (M-CSF), and interleukin-3 (IL-3), followed by immunophenotyping for myeloid and myeloid-associated cell surface markers. IL-3, either alone or together with GM-CSF, G-CSF, or M-CSF, induced, on average, 50-fold cell multiplication, GM-CSF five fold to 10-fold, and G-CSF and M-CSF less than fivefold. Cells from cultures stimulated with GM-CSF, G-CSF, or M-CSF alone contained cells with a "broad" myeloid profile, "broader" than observed in cultures with IL-3. However, since IL-3 induced rapid cell multiplication, high numbers of cells expressing early (CD13, CD33) and late myeloid markers (CD14, CD15) were recovered. The presence of other CSFs together with IL-3 did not alter the IL-3-induced effect on the cells. When 5,000 CD34+ cells were cultured with IL-3 alone, the cultures still contained 2,000 to 5,000 CD34+ cells after 14 days of culture, while cells cultured with GM-CSF, G-CSF, or M-CSF contained less than 1,000 CD34+ cells. Furthermore, 1,000 to 3,000 cells were positive for the megakaryocytic lineage marker CD41b after cultures with GM-CSF or IL-3, while cultures with G-CSF or M-CSF did not contain detectable numbers of CD41b+ cells. Finally, erythroid cells could also be generated from purified CD34+ cells. The results show that IL-3 and GM-CSF can induce rapid proliferation of purified CD34+ cells in vitro with differentiation to multiple myeloid lineages, while certain subsets maintain expression of CD34.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1720697

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

Review 1.  Molecular characterization of CD34+ human hematopoietic progenitor cells.

Authors:  W Knapp; H Strobl; C Scheinecker; C Bello-Fernandez; O Majdic
Journal:  Ann Hematol       Date:  1995-06       Impact factor: 3.673

2.  Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells.

Authors:  Aditi Bapat; Nakia Keita; Shalini Sharma
Journal:  J Vis Exp       Date:  2019-08-09       Impact factor: 1.355

3.  MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.

Authors:  R Su; H-S Lin; X-H Zhang; X-L Yin; H-M Ning; B Liu; P-F Zhai; J-N Gong; C Shen; L Song; J Chen; F Wang; H-L Zhao; Y-N Ma; J Yu; J-W Zhang
Journal:  Oncogene       Date:  2014-09-01       Impact factor: 9.867

4.  Effects of 2',3'-dideoxynucleosides on proliferation and differentiation of human pluripotent progenitors in liquid culture and their effects on mitochondrial DNA synthesis.

Authors:  A Faraj; D A Fowler; E G Bridges; J P Sommadossi
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

5.  Increased expression of RUNX3 inhibits normal human myeloid development.

Authors:  Ana Catarina Menezes; Rachel Jones; Alina Shrestha; Rachael Nicholson; Adam Leckenby; Aleksandra Azevedo; Sara Davies; Sarah Baker; Amanda F Gilkes; Richard L Darley; Alex Tonks
Journal:  Leukemia       Date:  2022-04-30       Impact factor: 12.883

6.  T lymphocyte differentiation in vitro from adult human prethymic CD34+ bone marrow cells.

Authors:  G E Tjønnfjord; O P Veiby; R Steen; T Egeland
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

7.  MicroRNA-10a/b are regulators of myeloid differentiation and acute myeloid leukemia.

Authors:  Laixi Bi; Lan Sun; Zhenlin Jin; Shenghui Zhang; Zhijian Shen
Journal:  Oncol Lett       Date:  2018-02-14       Impact factor: 2.967

8.  CD97 is a critical regulator of acute myeloid leukemia stem cell function.

Authors:  Gaëlle H Martin; Nainita Roy; Sohini Chakraborty; Alexis Desrichard; Stephen S Chung; Carolien M Woolthuis; Wenhuo Hu; Iryna Berezniuk; Francine E Garrett-Bakelman; Jörg Hamann; Sean M Devlin; Timothy A Chan; Christopher Y Park
Journal:  J Exp Med       Date:  2019-08-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.